Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity. Issue 2 (December 2015) - Grossenbacher, Steven; Ames, Erik; Mac, Stephanie; Duan, Yuyou; Azeem, Syed; Canter, Robert; Murphy, William